Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q3685951> ?p ?o }
Showing triples 1 to 27 of
27
with 100 triples per page.
- Q3685951 subject Q8248590.
- Q3685951 abstract "Conatumumab (originally AMG 655) is a monoclonal antibody developed for the treatment of cancer. it is a fully human monoclonal agonist antibody directed against the extracellular domain of human TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) receptor 2 (TR-2, death receptor 5) with potential antineoplastic activity. Conatumumab mimics the activity of native TRAIL, binding to and activating TR-2, thereby activating caspase cascades and inducing tumor cell apoptosis. TR-2 is expressed by a variety of solid tumors and cancers of hematopoietic origin.The drug was developed by Amgen Inc.".
- Q3685951 atcPrefix "none".
- Q3685951 casNumber "896731-82-1".
- Q3685951 fdaUniiCode "1P48L61KM0".
- Q3685951 wikiPageWikiLink Q128581.
- Q3685951 wikiPageWikiLink Q14599311.
- Q3685951 wikiPageWikiLink Q14877599.
- Q3685951 wikiPageWikiLink Q16242548.
- Q3685951 wikiPageWikiLink Q18033388.
- Q3685951 wikiPageWikiLink Q2579343.
- Q3685951 wikiPageWikiLink Q25805.
- Q3685951 wikiPageWikiLink Q422248.
- Q3685951 wikiPageWikiLink Q470517.
- Q3685951 wikiPageWikiLink Q8248590.
- Q3685951 wikiPageWikiLink Q919283.
- Q3685951 wikiPageWikiLink Q974135.
- Q3685951 atcPrefix "none".
- Q3685951 casNumber "896731".
- Q3685951 unii "1".
- Q3685951 type ChemicalSubstance.
- Q3685951 type Drug.
- Q3685951 type ChemicalObject.
- Q3685951 type Thing.
- Q3685951 type Q8386.
- Q3685951 comment "Conatumumab (originally AMG 655) is a monoclonal antibody developed for the treatment of cancer. it is a fully human monoclonal agonist antibody directed against the extracellular domain of human TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) receptor 2 (TR-2, death receptor 5) with potential antineoplastic activity. Conatumumab mimics the activity of native TRAIL, binding to and activating TR-2, thereby activating caspase cascades and inducing tumor cell apoptosis.".
- Q3685951 label "Conatumumab".